Doença policística renal autossômica dominante
Revisado por Dr Philippa Vincent, MRCGPÚltima atualização por Dr Toni Hazell, FRCGPÚltima atualização 10 Sept 2026
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
Profissionais de Saúde
Os artigos de Referência Profissional são projetados para uso por profissionais de saúde. Eles são escritos por médicos do Reino Unido e baseados em evidências de pesquisa, diretrizes do Reino Unido e da Europa. Você pode encontrar o Doença renal policística artigo mais útil, ou um dos nossos outros artigos de saúde.
Sinônimo: doença policística renal autossômica dominante
This is the most common inherited cause of serious renal disease and is caused by a gene mutation affecting polycystins. Polycystins regulate tubular and vascular development in the kidneys but also in other organs including the liver, brain, arterial blood vessels, and pancreas, causing extra-renal manifestations of the disease.
Epidemiologia1
Approximately 12.5 million individuals are affected in the world and they account for around 10% of patients with end-stage kidney disease (ESKD).
Between 6 and 9 people per million of the population have ESKD due to ADPKD.
A incidência por sexo é igual, embora os homens possam ser afetados de forma um pouco mais grave.
Transmissão1
ADPKD is transmitted genetically.
It is an autosomal dominant condition and is thought to be of high or complete penetrance.
The defect is commonly on chromosome 16 (PKD1, 85% of all ADPKD) or 4 (PKD2, 15% of all ADPKD), with some gene defects probably yet to be discovered234
10 -15% of patients with ADPKD have no family history of the disease, leading to the assumption that there is a significant rate of de novo mutations, although in some cases this may be due to ancestors with ADPKD having gone undiagnosed.5
Assim como em outras doenças autossômicas dominantes:
Se um dos pais tiver a doença, há uma chance de 50% de transmissão para os descendentes.
If both parents have the disease as heterozygotes, there is a 50% chance that the fetus will carry the disease in a heterozygous manner, a 25% chance of normality but a 25% chance of being a homozygote for the disease.
Apresentação1
Most individuals present with complications of autosomal dominant polycystic kidney disease, as symptoms may not present until the 30s or later. However, increasing numbers are being detected by screening individuals who have an affected relative.
Symptomatic patients may present with:
Haematuria (visible or non-visible).
Loin pain (the commonest symptom). Loin pain may be due to the condition itself, including cyst haemorrhage, infection, torsion or rupture, or due to associated renal stones.
Recurrent urinary tract infections, both upper and lower.
Mass effects from enlarged kidneys, including dyspnoea, early satiety, gastro-oesophageal reflux, low back pain, ascites, oesophageal varices, and obstructive jaundice.
Examination may find an abdominal mass which may represent enlarged kidneys or related hepato- or splenomegaly.
Complicações incluem:
Hypertension (sometimes presenting in childhood), with associated left ventricular hypertrophy.
Renal stones (twice as common as in the general population) and early renal failure.
Infertilidade masculina, which is a rare complication but can be due to cysts in the seminal vesicles and defective sperm motility.
Recurrent pancreatitis due to pancreatic cysts.
Intracranial haemorrhage due to arachnoid membrane cysts or berry aneurysms. A ruptured cerebral aneurysm is four times more likely in someone with ADPKD compared to the general population and increases further if there is a personal or family history of cerebral aneurysm or subarachnoid haemorrhage. It is also more common with increasing age and in women than in men and tends to occur at a lower age than in the general population.
Cardiac complications including cardiomyopathy,6 mitral valve prolapse and aortic regurgitation.
Diverticulosis, present in up to 50% of those with ADPKD.
Câncer de células renais is no more common than in the general population but tends to present at an earlier age.
Abdominal hernias.
Triagem7
A PKDAD começa no útero, mas podem passar várias décadas antes que os sintomas ou sinais da doença apareçam. A triagem oferece um meio de detectar indivíduos assintomáticos. Deve haver aconselhamento adequado antes da triagem.
Benefits of screening include:
Family planning and reproductive choice, particularly with the advent of preimplantation genetic testing.
Detecção precoce e tratamento de complicações da doença.
Seleção de membros da família não afetados para transplante de doador vivo.
Os riscos de testar incluem:
Discriminação possível em relação ao seguro e ao emprego.
Psychological effects of living with a disease without effective treatment, although with the advent of new.
A triagem de crianças assintomáticas não é atualmente recomendada, pois a retirada de sua escolha de saber e os possíveis efeitos adversos do diagnóstico são considerados que superam os benefícios. No entanto, isso é controverso e muitos defendem uma triagem mais precoce com ultrassonografia mais confiável e os possíveis benefícios da detecção precoce da hipertensão.
Screening may be done using ultrasound, CT, or MRI, to look for the characteristic renal cysts, or with genetic testing. Decisions on screening and genetic counselling would always be made in secondary care. The consultant of a patient with ADPKD may write to the GP to ask them to refer certain relatives for a discussion about screening.
Diagnóstico diferencial1
The differential diagnosis includes the following:
Cistos adquiridos e simples do rim.
Doença renal policística autossômica recessiva (formerly called polycystic kidney disease of childhood).
Von Hippel-Lindau syndrome.
Síndrome de Bardet-Biedl
Gestão7 8
Geral
Advice against participating in contact sports which risk abdominal trauma, such as rugby or boxing, as this can provoke haematuria or even cause the rupture of an enlarged kidney.
Lifestyle advice regarding avoiding smoking, maintenance of a healthy body weight, diet (eg, limiting salt intake), and regular exercise (ideally of a low-impact nature, such as swimming or walking). This is because much of the morbidity and mortality of ADPKD is due to CVD.
Cuidados primários
Early detection and management of hypertension - monitoramento ambulatorial da pressão arterial in young adults or children can reveal raised blood pressure not detected with the one-off blood pressure reading.
Treatment of urinary tract infections when they occur.
Being aware of possible complications such as renal colic and for the need to treat this with significant analgesia or referral if there are risks such as infection.
Ideally, the avoidance of anticoagulants in patients with ongoing haematuria, though the balance of risk and benefits may vary and a discussion between primary and secondary care may be useful.
Avoidance of nephrotoxic drugs such as non-steroidal anti-inflammatory drugs (NSAIDs).
Contraceptive considerations; oestrogen may increase the growth of hepatic cysts, so a copper or levonorgestrel intrauterine device or a progestogen only method may be a better choice for this cohort than combined hormonal contraception.9
Management of the menopause - oestrogen may increase cyst size, but this should be balanced against the benefits of hormone replacement therapy on menopausal symptoms, in a cohort who may already have significant cysts and be on the journey to renal transplantation by this age. If in doubt, discuss with the woman's specialist and/or a menopause specialist.
Referral for obstetrician led care (in conjunction with a renal specialist) if a woman becomes pregnant. Those with pre-conceptual hypertension or renal insufficiency are at higher risk of severe hypertension or pre-eclampsia. Normotensive women generally have uncomplicated pregnancies.
Cuidados secundários
Tolvaptan, a vasopressin receptor antagonist which has been shown to slow the growth of cystic kidneys and the deterioration of renal function. It is approved by NICE for patients with chronic kidney disease (CKD) 2 or 3 at the start of treatment, who have evidence of rapidly progressing disease.10
Annual blood tests and imaging to monitor progression.
Possible involvement of the pain clinic for chronic unrelenting pain caused by large cysts; a surgical approach to these is also sometimes taken.
Dialysis or renal transplantation if ESKD occurs. Transplante renal has similar outcomes for patients with ADPKD as for those without the disease. It is very important to exclude affected relatives as living donors (usually with MRI +/- gene testing).
Prognóstico11
Há uma grande variabilidade inter-familiar e intra-familiar na gravidade das manifestações renais e extra-renais; no entanto:
50 - 75% of those with ADPKD will develop ESKD by the age of 70, with 25% having reached this point by the age of 47 in one study.
Fatores de risco para progressão incluem:
Genótipo PKD1.
.
Afro-Caribbean race.
Sexo masculino.
Idade de início mais jovem.
Rins grandes.
Hipertensão.
Os biomarcadores que correlacionam com a progressão incluem aumento da secreção de sódio na urina, osmolalidade urinária e níveis mais baixos de HDL-C.
Atualizações exclusivas para profissionais de saúde
Mantenha-se informado com as últimas atualizações clínicas, insights profissionais e orientações baseadas em evidências. O boletim informativo Patient Pro seleciona conteúdo essencial para profissionais de saúde—entregue diretamente na sua caixa de entrada.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.
Leitura adicional e referências
- Mahboob M, Rout P, Rizwan S, Bokhai A; Polycystic Kidney Disease
- Policistina 1 (PKD1) - Doença Poliquística do Rim de Tipo 1 em Adultos; Herança Mendeliana Online no Homem (OMIM)
- Policistina 2 (PKD2) - Doença Renal Policística Adulto Tipo 2; Herança Mendeliana Online no Homem (OMIM)
- Doença Poliquística dos Rins Adultos 3, Autosômica Dominante (PKD3); Herança Mendeliana Online no Homem (OMIM)
- Bergmann C, Guay-Woodford LM, Harris PC, et al; Doença renal policística. Nat Rev Dis Primers. 6 de dezembro de 2018;4(1):50. doi: 10.1038/s41572-018-0047-y.
- Morita H; Cardiomiopatia secundária na Síndrome da Doença Renal Policística. Int Heart J. 2019;60(1):10-11. doi: 10.1536/ihj.18-514.
- Gimpel C, Bergmann C, Bockenhauer D, et al; Declaração de consenso internacional sobre o diagnóstico e manejo da doença renal policística autossômica dominante em crianças e jovens. Nat Rev Nephrol. 2019 Nov;15(11):713-726. doi: 10.1038/s41581-019-0155-2.
- Torra R; Avanços recentes no manejo clínico da doença renal policística autossômica dominante. F1000Res. 29 de janeiro de 2019;8. doi: 10.12688/f1000research.17109.1. Coleção de 2019.
- Petrone M, Catania M, De Rosa LI, et al; Role of Female Sex Hormones in ADPKD Progression and a Personalized Approach to Contraception and Hormonal Therapy. J Clin Med. 2024 Feb 22;13(5):1257. doi: 10.3390/jcm13051257.
- Tolvaptan for treating autosomal dominant polycystic kidney disease; NICE, Oct 2015
- Cowley BD Jr; Progressão da Doença Renal Policística: Aprendendo com a Europa. Am J Nephrol. 2018;48(4):306-307. doi: 10.1159/000493326. Epub 2018 Out 22.
Sobre o revisorVer biografia completa

Dr Philippa Vincent, MRCGP
Médico Generalista, Autor Médico
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dra Philippa Vincent é um médico do NHS trabalhando no norte de Londres.
Mais sobre distúrbios congênitos e hereditários
- Acondroplasia
- Síndrome de Alport
- Hipotonia congênita benigna
- Doença granulomatosa crônica
- Problemas congênitos de ouvido
- Síndrome da rubéola congênita
- Malformações urogenitais congênitas
- Síndrome de Diamond-Blackfan
- Hemangiomas da pele
- Hamartomas
- Hemocromatose hereditária
- Homocistinúria
- síndrome de Klippel-Trénaunay
- Síndrome de Laurence-Moon
- Síndrome de Moebius
- Nanismo de Mulibrey
- Síndrome de Noonan
- Síndrome de Patau
- Doença de armazenamento de glicogênio de Pompe
- Talasemia


